+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids



Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids



Endocrinology 129(2): 1101-1103



Dopamine inhibits prolactin liberation acting via the D2 type receptor. Two different electrophysiological responses to dopamine have been shown to characterize two types of lactotroph isolated from the lactating female rat. It is now known that differential splicing of the pre-messenger RNA coding for the D2 receptor leads to the production of two D2 subtypes, D2415 and D2444. These subtypes differ in the region which is believed to be responsible for the binding of G proteins, and could thus lead to the activation of different intracellular second messenger systems. Here we show that the pre-messenger RNA for the D2 receptor is differentially spliced in such a way that the ratio D2415/D2444 is significantly different (2.91 .+-. 0.6 vs 1.29 .+-. 0.14) between two populations of lactotrophs, each enriched in cells showing one type of response to DA. We further show that the ratio D2415/D2444 can be changed by treatment of prolactin cells in primary culture with progesterone or testosterone. Estrogen did not change the ratio, but diminished the total amount of D2 cDNA. Regulation of differential splicing by sex steroids could provide a mechanism for modifying lactotroph responsiveness to DA in different physiological situations.

(PDF emailed within 0-6 h: $19.90)

Accession: 002072428

Download citation: RISBibTeXText

PMID: 1830267

DOI: 10.1210/endo-129-2-1101


Related references

Flag d2415 and flag d2444 unique mutants of dopamine d2 receptors d2415 and d2444 offer a novel approach for rapid purification of d2 receptors. Society for Neuroscience Abstracts 17(1-2): 815, 1991

Effects of the novel dopaminergic agent OPC-14597 on dopamine D-2 receptors in lactotroph cells in rat anterior pituitary gland. Japanese Journal of Pharmacology 67(SUPPL 1): 161P, 1995

Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression. Human Molecular Genetics 24(18): 5299-5312, 2016

Dopaminergic regulation of striatal tachykinin gene expression i. interaction of d 1 and d 2 dopamine receptors. Society for Neuroscience Abstracts 14(2): 874, 1988

Regulation of dopamine D2 receptor expression in grass carp pituitary cells: a possible mechanism for dopaminergic modification of luteinizing hormone synthesis. General and Comparative Endocrinology 173(1): 48-55, 2011

Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. Faseb Journal 20(8): 1263-1265, 2006

Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition. Endocrinology 132(2): 832-838, 1993

Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation. European Neuropsychopharmacology 26(11): 1794-1805, 2016

Dopamine receptors and behavior Modification by dopaminergic lesions and intrastriatal fetal cell grafts. Society for Neuroscience Abstracts 18(1-2): 1537, 1992

Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly. Journal of Clinical Endocrinology and Metabolism 94(6): 1931-1937, 2009

Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum part 2 distribution and characteristics of dopamine adenylate cyclase interaction of d lsd with dopaminergic receptors. Brain Research 107(2): 303-315, 1976

Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. I. Mictoestimation of [3H] dopamine uptake and dopamine content in microdiscs. Brain Research 107(2): 291-301, 1976

Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors. Brain Research 107(2): 301-315, 1976

Gonadotroph-lactotroph associations and expression of prolactin receptors in the equine pituitary gland throughout the seasonal reproductive cycle. Journal of Reproduction and Fertility 119(2): 223-231, 2000

Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140(11): 5348-5355, 1999